FDA Inspection 1209864 — Takeda Development Center Americas
The FDA completed an inspection of Takeda Development Center Americas on June 5, 2023 in Lexington, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 5, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lexington, MA (United States)
Additional Details
Sponsor, Contract Research Organization